Skip to content

Acupuncture for Vulvodynia: A Pre-pilot Study

Acupuncture for Vulvodynia: A Double-blinded Feasibility Pre-pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02704234
Enrollment
6
Registered
2016-03-09
Start date
2018-02-23
Completion date
2022-11-07
Last updated
2024-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyspareunia, Pain, Vulvar Vestibulitis, Vulvodynia

Brief summary

Vulvodynia is a women's pain condition. Women have pain in their vulva, the area in their genitals between the vagina and labia (lips of the vagina). They also have pain when they have sexual intercourse or insert anything in the vagina. Sometimes they have so much pain, that they cannot have sex. This research is being done for two reasons. The first reason is to test a set of special needles called double-blinded acupuncture needles to give acupuncture treatments (one is a real needle and the other is a fake needle). The second reason is to develop a protocol (checklist) that will be used in this and future studies, and to identify and resolve any procedural problems. The protocol will be first tested by the principal investigator who is also an acupuncturist. The investigator will perform acupuncture using the protocol, if necessary change the protocol, and then teach a second acupuncturist using the modified protocol how to use the double-blinded acupuncture needles. The real needle called the penetrating needle penetrates the skin. The fake needle called the non-penetrating placebo touch needle does not penetrate the skin but it touches the skin so it feels like a needle is being inserted. It has a blunt tip. Participants can't see which needle they are getting acupuncture with because the needles are housed in a double-blinded needle device which has two tubes (an inner and an outer) that neither the acupuncturists nor the participants can see through. If a fake acupuncture needle can be used in acupuncture research like a sugar pill is used for drug studies to see how well the real medicine works, the investigators can see how effective acupuncture is. The investigators will be testing these needles to treat participants with vulvodynia.

Interventions

Active Acupuncture two times per week for 5 weeks

OTHERPlacebo Acupuncture

Placebo Acupuncture two times per week for 5 weeks

Sponsors

University of Illinois at Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* women previously diagnosed with generalized vulvodynia * women previously diagnosed with localized vestibulodynia,

Exclusion criteria

* pregnancy * menopause * interstitial cystitis * irritable bowel syndrome * untreated vaginitis * cervicitis * pelvic inflammatory disease * any other pelvic pathology causing pain * concomitant physical therapy * concomitant biofeedback * concomitant massage * additional acupuncture

Design outcomes

Primary

MeasureTime frameDescription
Change in Vulvar Pain Scalebaseline and twice weekly for 5 weeksPainReportIt, the computerized McGill Pain Questionnaire
Change in Dyspareunia Questionnairebaseline and once per week for 5 weeksFemale Sexual Function Index

Secondary

MeasureTime frameDescription
Vulvar Function Status Questionnaireat baseline and 5 weeksAssesses vulvar function

Other

MeasureTime frameDescription
Sleep Quality Scaleat baseline and 5 weeksPittsburgh Sleep Quality Index
The Protocol Acceptability Scale for Treating Vulvodynia with Acupuncture5 weeksAcceptability of the acupuncture protocol for the participant
Double-Blinded Needle Questionnaires for the Acupuncturist and for the Participant5 weeksAssesses the Ability of the Acupuncturist and Subject to Remain Blind

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026